Tandem Investment Advisors Inc. raised its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 781.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,094 shares of the company’s stock after purchasing an additional 16,041 shares during the period. Tandem Investment Advisors Inc.’s holdings in Procter & Gamble were worth $3,134,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in PG. Acorn Creek Capital LLC lifted its holdings in shares of Procter & Gamble by 2.8% during the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after buying an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. raised its stake in Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after purchasing an additional 59 shares in the last quarter. Alera Investment Advisors LLC boosted its holdings in Procter & Gamble by 1.2% in the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after purchasing an additional 60 shares during the period. Hudson Value Partners LLC increased its holdings in shares of Procter & Gamble by 4.1% during the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after purchasing an additional 60 shares during the period. Finally, Traveka Wealth LLC increased its holdings in shares of Procter & Gamble by 1.7% during the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after purchasing an additional 60 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Stock Up 1.5 %
Shares of NYSE PG opened at $163.41 on Friday. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The firm has a market cap of $384.84 billion, a PE ratio of 28.17, a P/E/G ratio of 3.57 and a beta of 0.42. The company’s fifty day simple moving average is $171.29 and its 200 day simple moving average is $168.13.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.46%. Procter & Gamble’s dividend payout ratio is presently 69.48%.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on PG shares. Royal Bank of Canada reissued a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research report on Monday, October 21st. Morgan Stanley raised their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Stifel Nicolaus raised their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a report on Monday, July 22nd. Finally, Piper Sandler assumed coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target for the company. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $177.00.
Get Our Latest Report on Procter & Gamble
Insider Activity at Procter & Gamble
In related news, CEO Jon R. Moeller sold 31,797 shares of the company’s stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the completion of the sale, the chief executive officer now owns 300,777 shares in the company, valued at approximately $50,897,483.94. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Procter & Gamble news, CEO Jon R. Moeller sold 31,797 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total value of $5,380,688.34. Following the completion of the sale, the chief executive officer now owns 300,777 shares in the company, valued at approximately $50,897,483.94. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total value of $16,320,000.00. Following the completion of the transaction, the chief executive officer now owns 13,721 shares in the company, valued at $2,332,570. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 313,597 shares of company stock valued at $53,268,499. 0.18% of the stock is owned by corporate insiders.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- Top Stocks Investing in 5G Technology
- Realty Income: This Dividend Stock Is a Strong Inflation Hedge
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Breakout Alert: Qualcomm Just Hit The Rally Button
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.